Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 1/20 | 0.46 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.46 |
| ▸ | ACLY | P53396 | 1/20 | 0.37 |
| ▸ | ACACB | O00763 | 1/20 | 0.36 |
| ▸ | ACACA | Q13085 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | ACAT1 | P24752 | 1/20 | 0.34 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.34 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | CPT2 | P23786 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CTSK | P43235 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9129151 | 1.00 | CYP4F2 (0.46) | CYP4F2CYP4A11ACLYACACBACACA | |
| SCHEMBL8987098 | 1.00 | CYP4F2 (0.46) | CYP4F2CYP4A11ACLYACACBACACA | |
| SCHEMBL4650865 | 0.98 | CYP4F2 (0.43) | CYP4F2CYP4A11ACLYACACBACACA | |
| SCHEMBL4122676 | 0.92 | CYP4F2 (0.40) | CYP4F2CYP4A11ACLYACACBACACA | |
| SCHEMBL1661232 | 0.83 | DGAT1 (0.38) | CYP4F2CYP4A11TSHRDGAT1ELANE | |
| SCHEMBL23971207 | 0.82 | CYP4F2 (0.44) | CYP4F2CYP4A11ACLYACACBACACA | |
| SCHEMBL14809987 | 0.82 | TSHR (0.52) | CYP4F2CYP4A11ACLYTSHRKMT2A | |
| SCHEMBL28738660 | 0.82 | TSHR (0.52) | CYP4F2CYP4A11ACLYTSHRKMT2A | |
| SCHEMBL23970490 | 0.82 | CYP4F2 (0.44) | CYP4F2CYP4A11ACLYACACBACACA | |
| SCHEMBL14891456 | 0.82 | TSHR (0.52) | CYP4F2CYP4A11ACLYTSHRKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12617752-B2 | Rapidly metabolized lipid compound | BEIJING JITAI LIFE SCIENCES LTD (CN) | 2026-05-05 | — | — | US | disclosed |
| EP-4729507-A1 | RAPIDLY-METABOLIZED LIPID COMPOUND | Beijing Jitai Life Sciences Ltd (CN) | 2026-04-22 | — | — | EP | disclosed |
| US-20250161482-A1 | RAPIDLY METABOLIZED LIPID COMPOUND | Beijing Jitai Pharmaceutical Technology Co., Ltd. (CN) | 2025-05-22 | — | — | US | disclosed |
| US-20250026713-A1 | RAPIDLY METABOLIZED LIPID COMPOUND | Beijing Jitai Pharmaceutical Technology Co., Ltd. (CN) | 2025-01-23 | — | — | US | disclosed |
| WO-2024255415-A1 | RAPIDLY-METABOLIZED LIPID COMPOUND | 北京剂泰医药科技有限公司 | 2024-12-19 | — | — | WO | disclosed |
| US-20230348361-A1 | IONIZABLE LIPID COMPOUNDS | METIS TECHBIO CO., LTD. (CN) | 2023-11-02 | — | — | US | disclosed |
| US-20230346702-A1 | LIPID NANOPARTICLES | METIS TECHBIO CO., LTD. (CN) | 2023-11-02 | — | — | US | disclosed |
| US-20230346702-A1 | LIPID NANOPARTICLES | METIS TECHBIO CO., LTD. (CN) | 2023-11-02 | — | — | US | disclosed |
| WO-2023207101-A1 | IONIZABLE LIPID COMPOUNDS | Beijing Jitai Pharmaceutical Technology Co., Ltd. (CN) | 2023-11-02 | — | — | WO | disclosed |
| US-20230348361-A1 | IONIZABLE LIPID COMPOUNDS | METIS TECHBIO CO., LTD. (CN) | 2023-11-02 | — | — | US | disclosed |
| CN-111825546-A | Synthesis method of piparidic acid | 合肥市梓熤科技贸易有限公司 | 2020-10-27 | — | — | CN | disclosed |
| US-5492915-A | ANTIINFLAMMATORY AGENTS | RHONE-POULENC RORER S.A. (FR) | 1996-02-20 | — | — | US | disclosed |
| US-5366982-A | Antiinflammatory agents or antihistamines | RHONE-POULENC RORER S.A. (FR) | 1994-11-22 | — | — | US | disclosed |
| EP-0540604-A1 | SUBSTITUTED BICYCLIC BIS-ARYL COMPOUNDS EXHIBITING SELECTIVE LEUKOTRIENE B 4? ANTAGONIST ACTIVITY, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS | Aventis Pharma S.A. (FR) | 1993-05-12 | — | — | EP | disclosed |
| WO-1992001675-A2 | SUBSTITUTED BICYCLIC BIS-ARYL COMPOUNDS EXHIBITING SELECTIVE LEUKOTRIENE B4 ANTAGONIST ACTIVITY, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS | RHONE-POULENC RORER S.A. (FR) | 1992-02-06 | — | — | WO | disclosed |
| US-4714762-A | Antiarteriosclerotic substituted benzimidazol-2-yl-and 3H-imidazo[4,5-b]pyridin-2-yl-phenoxy-alkanoic acids and salts and esters thereof | WARNER-LAMBERT COMPANY (US) | 1987-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250026713-A1 | RAPIDLY METABOLIZED LIPID COMPOUND | SLC10A1, NPC1, POLRMT | CYP4F2 113/4885CYP4A11 39/4885ACLY 819/4885 |
| US-12617752-B2 | Rapidly metabolized lipid compound | LDLR, SLC10A1, LRAT | CYP4F2 405/4885CYP4A11 45/4885ACLY 966/4885 |
| US-20230348361-A1 | IONIZABLE LIPID COMPOUNDS | PHOSPHO1, SLC10A1, SLCO4C1 | CYP4F2 729/4885CYP4A11 127/4885ACLY 2108/4885 |
| US-20230346702-A1 | LIPID NANOPARTICLES | ABCB4, NPC1L1, CHMP4B | CYP4F2 1701/4885CYP4A11 813/4885ACLY 1055/4885 |
| US-20250161482-A1 | RAPIDLY METABOLIZED LIPID COMPOUND | NPC1, SLC10A1, POLRMT | CYP4F2 173/4885CYP4A11 51/4885ACLY 778/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.